• Sanofi, Regeneron to cut price of Praluent pharmatimes
    July 24, 2018
    Selina McKee Sanofi and Regeneron have pledged to make Praluent more accessible to patients as data show that the drug significantly cut the risk of cardiovascular events in high-risk patients.
PharmaSources Customer Service